Health company M42 positioned a deal with Oracle as its latest step to establish the UAE at the centre of the global market, with the pair deploying a product offering unified access to patient data.
Oracle stated M42 intends to use its Health Data Intelligence product on clinical, genomic and real-world data to boost management of chronic diseases and enable a host of other services.
These include mapping the health of populations and providing precise care.
Oracle stated M42 is on a mission to establish the UAE as “a global hub for healthcare innovation” and a leader in employing AI to overhaul the sector.
Dr. Ali Anees, CCO for UAE and Bahrain at M42, said the company is a long-term user of Oracle’s health products and has high expectations about what can be achieved through the combination of information detailed above.
The executive expects the work to speed detection, and deliver “more predictive insights” and tailored patient healthcare.
M42 hopes the Oracle products will advance ambitions to deliver comprehensive patient records which it expects to aid healthcare providers’ work by offering a big-picture overview.
It expects the unified approach and ability of AI to digest reams of data to help identify disease patterns and contributing factors.
AI is also being banked on to deliver swifter diagnoses and detection of emerging health trends.
The post M42 picks Oracle healthcare tech appeared first on Mobile World Live.